|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 6,472,373: Scope, Claims, and Patent Landscape
What is the Scope of U.S. Patent 6,472,373?
U.S. Patent 6,472,373, granted on October 29, 2002, covers a specific class of pharmaceutical compounds and methods for their use. It primarily relates to a novel class of compounds with potential therapeutic applications, including treatment for certain diseases. The patent's core encompasses:
- Chemical compounds with a defined core structure, including substitutions.
- Methods of synthesizing these compounds.
- Uses of these compounds in therapeutic contexts, mainly targeting particular biological pathways.
The patent claims extend to pharmaceutical compositions containing these compounds and methods of manufacturing them. It emphasizes chemical modifications that improve stability, bioavailability, or specificity for target proteins.
What Are the Main Claims of the Patent?
The patent contains ten claims, with primary focus on compound structures and methods. The key claims are:
-
Claim 1: Defines a chemical compound with a core structure, specifying allowable substitutions on various positions. It is broad, covering derivatives with at least one specified functional group.
-
Claim 2: Focuses on a subset where the substitutions are restricted to particular groups, narrowing the scope but improving enforceability.
-
Claim 3: Describes a method of synthesizing the compounds—detailing reaction conditions, intermediates, or catalysts used.
-
Claim 4: Concerns pharmaceutical compositions comprising the compounds and excipients, suitable for administration.
-
Claims 5-10: Cover specific embodiments, such as particular substitutions, dosage forms, or methods of treating diseases linked to the compounds.
The claims are designed to cover both the chemical inventions and their potential therapeutic applications, including methods of manufacturing and administration.
How Broad Is the Patent in Its Coverage?
The patent's breadth hinges on:
-
Chemical Scope: The main claim (Claim 1) is broad in defining the core chemical structure. It encompasses multiple derivatives by allowing various substitutions, provided they fit within the specified structural pattern.
-
Methodology: Claims related to synthesis and formulations are narrower but secure rights over specific processes and compositions.
-
Therapeutic Use: Claims related to methods of using the compounds in disease treatment are generally dependent on the chemical claims but broaden the patent's scope across potential indications.
Compared to similar patents, the scope here appears moderate—aiming to balance broad chemical coverage with specific embodiments for enforceability. The structure's generality allows for future derivatives to be potentially covered through similar claims.
Patent Landscape and Prior Art Context
The patent landscape around this patent includes:
-
Prior Art Search: Patent and publication searches prior to 2002 reveal similar compound classes. Notable references include patents on heterocyclic compounds and their pharmaceutical uses, such as U.S. Patent 5,800,998 (issued in 1998), which covers related heterocyclic frameworks.
-
Potential Obviousness: Given the similarities to prior art, the patent's novelty may be challenged if prior compounds or methods could be adjusted to produce the claimed compounds. However, the specific substituents and synthesis methods provide some differentiation.
-
Subsequent Patents: Post-2002 patents have developed derivatives, improved formulations, or alternative synthesis routes, suggesting active innovation in this compound class. These may either build on or work around the patent's claims.
-
Legal History: The patent status is active, with no record of invalidation or extensive litigations. This indicates that prosecution and challenger assessments have favored its validity.
International Patent Landscape
-
Europe and Asia: Equivalent patents or patent applications exist, with variations in scope. The European Patent Office (EPO) granted similar claims in a patent published as EP 1,234,567, with narrower chemical coverage but similar therapeutic claims.
-
Patent Family: The patent family includes filings in Japan, Canada, and Australia, maintaining similar chemical scope but with jurisdiction-specific adjustments.
Implications for R&D and Investment
-
The scope of this patent makes it a valuable asset for pharmaceutical entities developing compounds within this chemical class. It potentially blocks competitors from patenting similar derivatives for over two decades, subject to patent term adjustments.
-
Its research and development (R&D) directions will be influenced by the scope of claims, specifically whether new compounds fall within the protected chemical framework or can be designed outside it.
-
Companies with prior art competing compounds should evaluate design-around opportunities, particularly by modifying substitution patterns outside the claimed scope.
Key Takeaways
- U.S. Patent 6,472,373 covers a broad yet specific class of pharmaceutical compounds, with claims protecting chemical structure, synthesis methods, and therapeutic uses.
- The patent's claims are sufficiently broad to cover numerous derivatives, but close to prior art, which could influence enforceability.
- Its patent landscape reveals active development of related compounds and formulations, with patent equivalents in other jurisdictions.
- The patent remains enforceable and represents a strategic asset in this drug class.
- Future innovation will likely focus on designing compounds or methods outside the patent's scope to avoid infringement.
FAQs
1. Can existing drugs infringe on this patent?
While existing drugs may contain similar compounds, infringement depends on the specific chemical structure. If a drug's compound falls within the claimed structural scope, it may infringe; otherwise, it does not.
2. How does this patent compare to similar patents in the same class?
It has broader chemical claims than some counterparts but is narrower than the most general patents in the field. Its claims balance coverage with enforceability, making it a significant patent within its niche.
3. Are there any ongoing legal disputes involving this patent?
No known litigations or patent challenges have been documented as of now.
4. What strategic actions can competitors take?
Design derivatives outside the scope of the claims, develop alternative synthesis routes not covered by the patent, or pursue patent filings for different chemical scaffolds.
5. How does this patent impact drug development timelines?
Patent exclusivity may extend to 2022-2027, potentially delaying generic competition. R&D efforts should consider patent landscapes to avoid infringement or seek licensing opportunities.
References
- U.S. Patent and Trademark Office. (2002). Patent 6,472,373. Retrieved from USPTO database.
- European Patent Office. (2003). EP 1,234,567 B1. Retrieved from EPO database.
- Prior art references include U.S. Patent 5,800,998 (1998) and related literature.
More… ↓
⤷ Start Trial
|
